Table 1 Baseline characteristics of patients undergoing transcatheter ASD closure
From: Efficacy and safety of transcatheter closure in adults with large or small atrial septal defects
All patients (n = 107) | Large device group (n = 41) | Small device group (n = 66) | p value | |
|---|---|---|---|---|
Demographic characteristics | ||||
Age (years) | 48.9 ± 15.6 | 48.9 ± 14.7 | 48.9 ± 16.3 | 0.99 |
Gender (female), n (%) | 61 (57) | 22 (54) | 39 (59) | 0.69 |
Medical history, n (%) | ||||
NYHA I | 65 (61) | 26 (63) | 39 (59) | 0.69 |
NYHA II | 32 (30) | 11 (27) | 21 (32) | 0.67 |
NYHA III | 9 (8) | 3 (7) | 6 (9) | 1.00 |
NYHA IV | 1 (1) | 1 (2) | 0 (0) | 0.38 |
Atrial fibrillation | 13 (12) | 7 (17) | 6 (9) | 0.24 |
Right axis deviation on ECG | 11 (9) | 8 (20) | 2 (3) | 0.007 |
Arterial hypertension | 26 (24) | 10 (24) | 16 (24) | 1.00 |
Diabetes mellitus | 4 (4) | 3 (7) | 1 (2) | 0.16 |
Dyslipidemia | 20 (19) | 6 (15) | 14 (21) | 0.45 |
Stroke/TIA | 23 (21) | 5 (12) | 18 (27) | 0.09 |
ASD characteristics | ||||
Defect size (mm) | 24 (16, 27) | 27 (24, 34) | 19 (14, 24) | <0.0001 |
Multiple defects, n (%) | 9 (8) | 3 (7) | 6 (9) | 1.00 |
Device size (mm) | 24 (18, 28) | 30 (26, 34) | 20 (16, 24) | <0.0001 |